We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Fresenius Secures Preliminary Injunction to Block Fera’s Levothyroxine Sodium Generic
Fresenius Secures Preliminary Injunction to Block Fera’s Levothyroxine Sodium Generic
A federal judge awarded Fresenius a preliminary injunction that blocks Fera Pharmaceuticals from marketing a levothyroxine sodium generic for the treatment of an underactive thyroid.